News for Healthier Living

New Study Reveals How Blood Cancers Outsmart BTK-Targeted Therapies

Researchers have uncovered a rare genetic mutation that enables some blood cancers to evade both approved Bruton tyrosine kinase (BTK) inhibitors and newer BTK degraders, a finding that could help shape the next generation of therapies for patients with chronic lymphocytic leukemia (CLL) and related malignancies.

July 27, 2026


July 28 2026

July 27 2026

July 26 2026

July 25 2026

July 24 2026

July 23 2026

July 22 2026

July 21 2026

July 20 2026

July 17 2026

July 16 2026

July 15 2026

July 14 2026